Paper12945875
Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study.
Alikhan R and 9 others. Blood Coagul Fibrinolysis, 2003. Cited by 193 papers, by iCite.
Cite this record
ConductScience Library. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Papers, record 12945875. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12945875
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticoagulants | Major topic |
| Enoxaparin | Major topic |
| Venous Thrombosis | Major topic |
| Aged | |
| Aged, 80 and over | |
| Chronic Disease | |
| Dose-Response Relationship, Drug | |
| Double-Blind Method | |
| Female | |
| Heart Failure | |
| Humans | |
| Male | |
| Middle Aged | |
| Movement | |
| Multicenter Studies as Topic | |
| Neoplasms | |
| Obesity | |
| Randomized Controlled Trials as Topic | |
| Respiratory Insufficiency | |
| Thromboembolism | |
| Treatment Outcome | |
| Varicose Veins | |
| Walking |
Source PubMed
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 193 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42479201 | Pharmacological thromboprophylaxis in hospitalized patients with acute infectious diseases: a meta-analysis. | Eur J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42479201 | PubMed |
| 40108695 | The efficacy of atorvastatin on inflammation and coagulation markers in high-risk thrombotic cancer patients undergoing chemotherapy: a randomized controlled trial. | Thromb J | 2025 | https://conductscience.org/library/papers/40108695 | PubMed |
| 39736980 | Risk stratification and contributing factors of deep vein thrombosis among patients admitted at Debre Markos comprehensive specialized hospital, Ethiopia in 2024. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39736980 | PubMed |
| 38893201 | Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38893201 | PubMed |
| 38507055 | Incidence and characteristic of deep venous thrombosis in hospitalized chronic heart failure patients. | Heart Vessels | 2024 | https://conductscience.org/library/papers/38507055 | PubMed |
| 38432204 | Venous Thromboembolism Prophylaxis in Inflammatory Bowel Disease Inpatients: Systematic Review and Meta-Analysis. | Acta Haematol | 2024 | https://conductscience.org/library/papers/38432204 | PubMed |
| 37150824 | The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy : A randomised controlled trial: open label. | Thromb J | 2023 | https://conductscience.org/library/papers/37150824 | PubMed |
| 36867519 | Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia. | Ann Am Thorac Soc | 2023 | https://conductscience.org/library/papers/36867519 | PubMed |
| 35898299 | Correlation of Inflammation and Coagulation Markers with the Incidence of Deep Vein Thrombosis in Cancer Patients with High Risk of Thrombosis. | Int J Gen Med | 2022 | https://conductscience.org/library/papers/35898299 | PubMed |
| 35595804 | The effect of intermittent pneumatic compression on deep-vein thrombosis and ventilation-free days in critically ill patients with heart failure. | Sci Rep | 2022 | https://conductscience.org/library/papers/35595804 | PubMed |
| 35414101 | Evaluation of the Padua Prediction Score ability to predict venous thromboembolism in Israeli non-surgical hospitalized patients using electronic medical records. | Sci Rep | 2022 | https://conductscience.org/library/papers/35414101 | PubMed |
| 34878173 | Anticoagulation for the initial treatment of venous thromboembolism in people with cancer. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/34878173 | PubMed |
| 34622445 | Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/34622445 | PubMed |
| 34327882 | Heart Failure Is Associated with Increased Risk of Long-Term Venous Thromboembolism. | Korean Circ J | 2021 | https://conductscience.org/library/papers/34327882 | PubMed |
| 33570602 | American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. | Blood Adv | 2021 | https://conductscience.org/library/papers/33570602 | PubMed |
| 32989908 | COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward. | Clin Transl Sci | 2020 | https://conductscience.org/library/papers/32989908 | PubMed |
| 32692862 | Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19. | J Thromb Haemost | 2020 | https://conductscience.org/library/papers/32692862 | PubMed |
| 32632822 | New insights on patient-related risk factors for venous thromboembolism in patients with solid organ cancers. | Int J Hematol | 2020 | https://conductscience.org/library/papers/32632822 | PubMed |
| 32540948 | Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow. | BMJ Open Qual | 2020 | https://conductscience.org/library/papers/32540948 | PubMed |
| 32442298 | Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial. | Blood Adv | 2020 | https://conductscience.org/library/papers/32442298 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12945875
GET https://conductscience.org/api/papers/v1/12945875/cited_by?page=2